PureTech Health plc has announced the appointment of immunology expert and former Genzyme group vice president, Bruce L. Roberts, Ph.D., as Chief Scientific Officer.
Additionally, Vedanta recently expanded into new headquarters, research and development and manufacturing facility in Cambridge, MA.
Daphne Zohar, CEO of PureTech said: “Vedanta has been pioneering the microbiome field and was the first to rationally design a drug candidate based on consortia of human commensal bacteria. Vedanta’s platform is built on validated science written up in multiple high impact publications in Science and Nature and attracted the first large deal with a pharmaceutical company in the microbiome field. With the addition of Bruce Roberts as CSO and the move to a new state-of-the-art facility, Vedanta is poised to continue to lead this exciting new field.”